Evidence map›Paper›PMID 24603665›Full record

ArticleToxins2014

Deoxynivalenol in the gastrointestinal tract of immature gilts under per os toxin application.

Agnieszka Waśkiewicz, Monika Beszterda, Marian Kostecki, Łukasz Zielonka, Piotr Goliński, Maciej Gajęcki

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Activity of Zearalenone in the Porcine Intestinal Tract.Molecules (Basel, Switzerland) · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Agnieszka WaśkiewiczDepartment of Chemistry, Poznań University of Life Sciences, Wojska Polskiego 75, Poznań 60-625, Poland. agat@up.poznan.pl.
Monika BeszterdaDepartment of Chemistry, Poznań University of Life Sciences, Wojska Polskiego 75, Poznań 60-625, Poland. monika.beszterda@up.poznan.pl.
Marian KosteckiDepartment of Chemistry, Poznań University of Life Sciences, Wojska Polskiego 75, Poznań 60-625, Poland. marian.kostecki@up.poznan.pl.
Łukasz ZielonkaDepartment of Veterinary Prevention and Feed Hygiene, University of Warmia and Mazury in Olsztyn, Olsztyn 10-719, Poland. lukasz.zielonka@uwm.edu.pl.
Piotr GolińskiDepartment of Chemistry, Poznań University of Life Sciences, Wojska Polskiego 75, Poznań 60-625, Poland. piotrg@up.poznan.pl.
Maciej GajęckiDepartment of Veterinary Prevention and Feed Hygiene, University of Warmia and Mazury in Olsztyn, Olsztyn 10-719, Poland. gajecki@uwm.edu.pl.
University of Life Sciences in Poznań · PLUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deoxynivalenol is also known as vomitoxin due to its impact on livestock through interference with animal growth and acceptance of feed. At the molecular level, deoxynivalenol disrupts normal cell function by inhibiting protein synthesis via binding to the ribosome and by activating critical cellular kinases involved in signal transduction related to proliferation, differentiation and apoptosis. Because of concerns related to deoxynivalenol, the United States FDA has instituted advisory levels of 5 µg/g for grain products for most animal feeds and 10 µg/g for grain products for cattle feed. The aim of the study was to determine the effect of low doses of deoxynivalenol applied per os on the presence of this mycotoxin in selected tissues of the alimentary canal of gilts. The study was performed on 39 animals divided into two groups (control, C; n = 21 and experimental, E; n = 18), of 20 kg body weight at the beginning of the experiment. Gilts received the toxin in doses of 12 µg/kg b.w./day (experimental group) or placebo (control group) over a period of 42 days. Three animals from two experimental groups were sacrificed on days 1, 7, 14, 21, 28, 35 and 42, excluding day 1 when only three control group animals were scarified. Tissues samples were prepared for high performance liquid chromatography (HPLC) analyses with the application of solid phase extraction (SPE). The results show that deoxynivalenol doses used in our study, even when applied for a short period, resulted in its presence in gastrointestinal tissues. The highest concentrations of deoxynivalenol reported in small intestine samples ranged from 7.2 (in the duodenum) to 18.6 ng/g (in the ileum) and in large intestine samples from 1.8 (in transverse the colon) to 23.0 ng/g (in the caecum). In liver tissues, the deoxynivalenol contents ranged from 6.7 to 8.8 ng/g.

Indexed as

Administration, OralAnimalsChromatography, High Pressure LiquidDietFemaleIntestine, LargeIntestine, SmallLiverSwineToxins, BiologicalTrichothecenesdeoxynivalenolToxins, BiologicalTrichothecenes

Identifiers

PMID24603665
PMCPMC3968371
OpenAlexW2046619957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.